Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com
Research analysts at StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Evoke Pharma Price Performance EVOK opened at $3.15 on Thursday. The stock has a market capitalization […]
Research analysts at StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Evoke Pharma Price Performance EVOK opened at $3.15 on Thursday. The stock has a market capitalization […]
